Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
1,248 news
and
4,696 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
Blogs
Recent blog posts on this topic.
Biotech industry honchos notched a first victory in their state-to-state campaign to raise the bar on use of...
Just days ahead of a big-time FDA decision on its oral multiple sclerosis pill, Biogen Idec grabbed the endorsement of...
Oliver Fetzer, CEO of Cerulean Pharma After raising more than $80 million in venture money, Cerulean Pharma failed its...
Copyright © thinkBiotech This chart shows the pharmaceutical drugs with the most patents still in force.
Titan Pharmaceuticals ($TTNP) emerged victorious from an FDA advisory committee meeting where the majority of...
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad)...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Shares of San Diego-based Acadia Pharmaceuticals ($ACAD) surged 28% this morning after the biotech spelled out some of...
Copyright © thinkBiotech I will be in Pittsburgh from April 4-5th to give a talk at Carnegie Mellon’s business school,...
Teva ($TEVA) and its multiple sclerosis partner Active Biotech rolled out some new top-line Phase III data on their...
Enanta Pharmaceuticals, which is partnered with AbbVie ($ABBV) on a hot new experimental therapy for hepatitis C, has...
Celgene has made a move into the resurgent gene therapy field. With a focus on immunotherapies against cancer, Celgene...
AZ CEO Pascal Soriot AstraZeneca's new CEO Pascal Soriot has wrapped his review of the Big Pharma company ($AZN) and...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a...
Biogen Idec has taken a couple of big steps forward in building up its blockbuster franchise for multiple sclerosis...
Aratana Therapeutics, which is developing 6 new treatments for cats and dogs, joined the biotech queue on Wall Street,...
Shares of Israel's BioLineRx ($BLRX) plunged 51% this morning when the biotech announced that it was shutting down a...
Top Sources: Business of Biotechnology
- Biotech Blog
- News
- Health Beat
- frontendofinnovation.blogspot.com
- Nature Biotechnology
- The Biotech Weblog
- policyinnovations.org
- Science Progress
- LinkedIn Answers: Technology
- World Pharma News / Published News
account